Verrica Pharmaceuticals buy Royal Bank of Canada
Start price
17:15
/
50%
€2.60
Target price
15.08.25
€11.83
Performance (%)
1.54%
Price
14.08.24
€4.70
Summary
This prediction is currently active. With a performance of 1.54%, the BUY prediction by Royal_Bank_of_Canada for Verrica Pharmaceuticals is trending in the right direction. This prediction currently runs until 15.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Verrica Pharmaceuticals | 1.54% |
iShares Core DAX® | 2.687% |
iShares Nasdaq 100 | 5.569% |
iShares Nikkei 225® | 3.756% |
iShares S&P 500 | 3.959% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Royal Bank of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
Ratings data for VRCA provided by MarketBeat